BioSpace News Archive

Business

Sareum Holdings plc Directorate Change: Michael Owen, PhD and Clive Birch appointed as Non-Executive Directors

Sareum Holdings plc is pleased to announce the appointments of Michael Owen, PhD and Clive Birch as Non-Executive Directors.

November 21, 2018
·
4 min read
Business

HOX THERAPEUTICS APPOINTS KARL KEEGAN AS CHIEF EXECUTIVE OFFICER

Developing Targeted Therapies With Potential Applicability Across Many Cancer Types

November 21, 2018
·
3 min read
Policy

Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System

Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease

November 21, 2018
·
3 min read
Job Trends

Understanding Congenital Heart Defects To Prevent Them

UH Engineer Using Optical Equipment to Watch Heart Develop

November 21, 2018
·
2 min read
Business

AusCann appoints PCI Pharma to manufacture its first medicinal cannabis product line

AusCann appoints TGA licensed PCI Pharma to manufacture and release its first medicinal cannabis product line.

November 21, 2018
·
3 min read
Business

Medigene reports financial & business results for the first nine months of 2018

Medigene AG today reported financial results for the first 9 months of 2018 and provided a review of recent accomplishments and anticipated upcoming milestones.

November 21, 2018
·
6 min read
Business

Azeria Therapeutics announces appointment of Dr Julian Blagg DPhil. FRSC as VP Drug Discovery

Azeria Therapeutics Limited, a newly formed drug discovery company, today announced the appointment of Dr Julian Blagg as VP Drug Discovery.

November 21, 2018
·
2 min read
Business

Polarean Imaging Plc Licencing Agreement with Duke University

Polarean Imaging plc provides shareholders with the following update on Company progress

November 21, 2018
·
2 min read
Business

IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers

IntegraGen today announced it will be collaborating with Google Cloud for the implementation of IntegraGen’s advanced genomic analysis tools, SIRIUS™ and MERCURY™ into the Google Cloud Platform.

November 21, 2018
·
4 min read
FDA

Sobi’s Recently-Acquired Gamifant Gets FDA Approval for Ultra-Rare Disease

Sweden-based Sobi and Swiss-based Novimmune announced the U.S. approval of Gamifant (emapalumab-lzsg) to treat an ultra-rare disease in adults and children. Sobi’s U.S. offices are in Waltham, Mass.

November 21, 2018
·
3 min read
·
Mark Terry